Program News
News and stories about members of the UNC Lineberger Molecular Therapeutics Research Program
-
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
-
Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed
UNC Lineberger researchers have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene, and how its activities impact pancreatic cancer outcomes.
-
UNC researchers to present at American Society of Clinical Oncology annual meeting
UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the ASCO Annual Meeting.
-
A few minutes with Siddharth Sheth, DO, MPH
For Siddharth Sheth, DO, MPH, he knew UNC was the place for him when he pursued his first faculty position in medicine. However, it wasn’t just UNC that shaped his medical career. When Sheth’s mom was diagnosed with cancer and later relapsed, he knew oncology was the right path for him.
-
Newly engineered molecule bypasses toxicity previously found in key cancer-fighting pathway
UNC Lineberger researchers have developed a molecule that is much more effective than a previously identified molecule at activating a biological pathway and spurring a strong anti-cancer immune response in preclinical studies.
-
Yeh, Johnson awarded five-year, $3.2 million research grant from NCI
The grant will support the first metastatic pancreatic cancer trial in the country to evaluate whether selecting treatment by tumor subtype will help patients match to more effective first-line therapies.
-
How medical advances are improving glioblastoma care
Neuro-oncologist Soma Sengupta, MD, PhD, discusses glioblastoma symptoms, standard treatment and clinical trials.
-
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
-
Inspired research: A conversation with Kirsten Bryant, PhD
Kirsten Bryant, PhD, shares what motivates her in the lab, how mentorship and advocacy have fueled her passion for pancreatic cancer research, and why she’s encouraged by progress made in the past decade.
-
Poor oral health could lessen survival from head and neck cancer
An international study has revealed strong associations between oral health and survival among people diagnosed with head and neck cancer.
-
NCI awards Pecot $1.8 million lung cancer research grant
The grant will support Chad Pecot, MD, and his research investigating the roles circular RNA may have in regulating whether a form of lung cancer will spread beyond the original cancer site.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
RNA discoveries drive oncologist’s next chapter
Physician-scientist and cancer survivor Chad Pecot, MD, is focused on RNA discoveries in the lab and the clinic.
-
Office of Graduate Education recognizes four Lineberger members with mentorship awards
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
-
Lung Cancer Initiative awards Pecot $100,000 grant
The grant supports Chad Pecot, MD, and his research into the mechanistic and therapeutic implications of co-targeting two genes linked to lung cancer.